Novo Nordisk A/S – Page 3 – Finance Tailwind

Viking Therapeutics falls 30% on drug data

Novo Nordisk offers diabetes drug Ozempic for steep cash discount

DAY, RUN, TSLA, NVO and more

Our top 3 gainers, laggards as the S&P 500 continues to hit records

We’re downgrading Lilly and asking ourselves tough questions after its obesity

Eli Lilly obesity pill orforglipron led to 12% weight loss

Hims & Hers (HIMS) Q2 earnings 2025

Trump asks drugmakers to cut U.S. prices within 60 days

Eli Lilly’s Mounjaro shows similar heart health benefits as Trulicity

Stocks making the biggest moves premarket: NVO, WHR, SRPT